Our cohort of 14 C9orf72 mutation patients represents the whole spectrum of clinical and neuropathological subtypes, including three cases each with either MND or FTLD and eight cases with a mixed disease. The gene discussed is C9orf72; the disease is mild neurocognitive disorder.